Skin Cancer Warning Signs: The ABCDE Rule Explained

What Is Skin Cancer?

Skin cancer is the uncontrolled growth of abnormal skin cells. It is the most common cancer in the United States — the American Academy of Dermatology (AAD) estimates that one in five Americans will develop skin cancer at some point in their lifetime, and millions of new cases are diagnosed annually. Despite this prevalence, skin cancer is also among the most preventable and, when caught early, among the most treatable cancers.

The three most common types differ fundamentally in origin, behavior, and risk:

Melanoma is described by the NCI as "a rare form of skin cancer" by percentage, yet it accounts for the vast majority of skin cancer deaths — nearly 20 Americans die of melanoma every day, according to AAD statistics. The NCI estimated 104,960 new melanoma cases and 8,430 deaths in the US in 2025.

The ABCDE Rule: The Primary Self-Screening Framework

The ABCDE rule was developed to give patients and clinicians a structured, memorable framework for evaluating pigmented lesions. Each letter represents a visual feature that distinguishes a potentially cancerous lesion from a benign mole.

A — Asymmetry

Draw an imaginary line through the center of a mole. In a benign mole, both halves should be mirror images of each other. A suspicious lesion has halves that do not match — one half may be larger, differently shaped, or differently pigmented than the other.

Normal moles are typically round or oval and symmetrical. Asymmetry is one of the earliest signs of malignant transformation.

B — Border

A benign mole has smooth, clearly defined, even edges. A suspicious lesion has an irregular, ragged, notched, blurred, or poorly defined border. The edge may appear to bleed into the surrounding skin, or sections of the border may have scalloped indentations.

The irregular border reflects the disorganized, invasive growth pattern of malignant cells.

C — Color

A normal mole is typically one uniform shade — usually tan, brown, or black. A suspicious lesion contains multiple colors within the same lesion — varying shades of brown, black, tan, gray, pink, red, white, or blue.

Color variability results from uneven distribution of melanin, areas of regression (where the immune system is partially destroying the tumor), and inflammation within the lesion. The American Cancer Society notes that concerning lesions may include "different shades of brown or black, or sometimes with patches of pink, red, white, or blue."

D — Diameter

Most benign moles are smaller than 6 millimeters across — approximately the diameter of a pencil eraser. A lesion larger than 6mm warrants evaluation. The AAD notes that melanomas are usually larger than 6mm at the time of diagnosis, though smaller melanomas do exist and diameter alone is not definitive.

Clinical note: Some dermatologists now use "D" to mean "Dark" rather than "Diameter" — this captures the fact that a lesion significantly darker than a patient's other moles, regardless of size, deserves attention.

E — Evolving

Perhaps the most actionable criterion: any mole or lesion that is changing over weeks to months in size, shape, color, or texture is suspicious and should be evaluated. Evolving changes may also include new symptoms — itching, tenderness, bleeding, or crusting in a previously stable mole.

A stable mole may have existed for decades without change. New growth, altered color, or a lesion that begins bleeding spontaneously removes the assumption of stability.

Beyond ABCDE: The Ugly Duckling Sign

The ABCDE rule has one important limitation: it evaluates each mole in isolation. The ugly duckling sign offers a complementary approach — identifying the one lesion that looks strikingly different from all the others on a person's body.

Most people develop moles with a consistent overall pattern. A lesion that looks noticeably different from all of a patient's other moles — the "odd one out" — warrants clinical assessment even if it does not technically trigger ABCDE criteria. A 2015 PMC review proposed combining ABCDE with the ugly duckling sign into a unified "ABCDEF" framework (F for "Funny looking") to capture this gestalt warning without overcomplicating the mnemonic.

The EFG Rule: Recognizing Nodular Melanoma

Nodular melanoma is one of the most aggressive melanoma subtypes, accounting for up to 14% of all melanomas but a disproportionately high share of melanoma deaths — because it grows rapidly vertically (into the dermis) rather than spreading horizontally across the skin surface first.

Critically, nodular melanoma often does not display the standard ABCDE features. It may be small, symmetrical, have defined borders, and be a uniform dark color — and still be lethal.

Dermatologists use the EFG rule to flag nodular melanoma:

• E — Elevated: A raised, dome-shaped, or nodular growth rather than a flat spot
• F — Firm: Hard to the touch, unlike a soft, squishy cyst or lipoma
• G — Growing: Rapid growth over days to weeks rather than the slow change of ABCDE lesions

Any new raised, firm lesion growing rapidly — regardless of ABCDE status — should be evaluated promptly.

Skin Cancer Beyond Moles: Non-Melanoma Warning Signs

Basal cell carcinoma and squamous cell carcinoma — collectively called non-melanoma skin cancers — are far more common than melanoma but present very differently. They do not typically look like moles.

Basal Cell Carcinoma (BCC) Warning Signs

• A pearly or shiny bump with visible blood vessels (telangiectasias) on the surface — the classic nodular BCC appearance
• A flat, scar-like lesion that looks waxy and pale — often the morphoeic (sclerosing) subtype, which is more aggressive
• A pink or red scaly patch that doesn't heal, particularly on the chest or back (superficial BCC)
• A sore that bleeds, crusts, and partially heals, then bleeds again
• In darker skin tones, BCC may appear brown or black rather than pink, which can delay recognition

BCC almost always appears on sun-exposed areas: the head, neck, ears, nose, eyelids, and hands. It is extremely rare for BCC to metastasize, but it can grow deeply, invading cartilage and bone if left untreated.

Squamous Cell Carcinoma (SCC) Warning Signs

• A firm, rough, red or scaly nodule or persistent scaly patch, often in sun-exposed areas
• An open sore or wound that bleeds and doesn't heal within a few weeks
• A wart-like growth that crusts or bleeds
• A raised growth with a central depression that occasionally bleeds
• Lesions on the lip or inside the mouth — oral SCC is less sun-related and may be associated with HPV or tobacco use

Warning Signs That Apply to All Skin Cancers

Beyond the specific type-by-type patterns, the AAD identifies several features that apply broadly to any suspicious skin change:

• Spontaneous bleeding from a lesion — especially one that wasn't injured
• A sore that does not heal within 3–4 weeks
• Pigment spreading from a mole or lesion into the surrounding skin
• Redness or swelling outside the visible border of a mole
• Changed sensation — a previously painless mole that develops itching, tenderness, or pain
• Surface texture changes — oozing, crusting, or scaliness on a previously smooth lesion

Any of these features warrants an appointment with a board-certified dermatologist.

Where Skin Cancer Can Appear: Not Just Sun-Exposed Skin

A common misperception is that skin cancer only develops on areas that receive direct sun exposure. While UV exposure is the primary risk factor for most skin cancers, lesions can develop anywhere on the body, including:

• Scalp and hair-bearing areas (often missed in self-exams)
• Between the toes and on the soles of the feet — acral lentiginous melanoma is more common in people of color and occurs on non-sun-exposed skin
• Under fingernails and toenails — a dark band or streak under a nail (subungual melanoma) may appear as a dark line
• Palms of the hands
• Genitals and perianal skin
• Eyes (ocular melanoma) — appearing as dark spots on the iris
• Mucosal surfaces — mouth, nose, and throat

Subungual melanoma in particular is frequently misidentified as a fungal infection or benign pigmentation. A dark streak extending from the nail bed to the nail edge (the Hutchinson sign — darkening of the skin around the base of the nail) is a warning sign requiring evaluation.

Performing a Monthly Skin Self-Examination

The AAD recommends monthly head-to-toe self-skin examinations. A systematic approach ensures no area is missed:

1. Face and scalp: Use a comb to part hair and examine the scalp; use a hand mirror for the back of the head and neck
2. Ears: Both the front and back of each ear, including the earlobe
3. Trunk and torso: Examine front and back, including the underarms
4. Arms and hands: Between the fingers, under and around the fingernails, and the forearms and upper arms
5. Genitals: Often overlooked; melanoma can occur here
6. Legs and feet: The soles, between the toes, and under and around the toenails

Using two mirrors (a full-length and a hand mirror) or asking a partner to inspect the scalp and back improves coverage. Photograph moles to track changes over time — smartphone photos taken in consistent lighting at the same angle provide a useful baseline.

Risk Factors for Skin Cancer

Understanding risk helps calibrate vigilance. Higher-risk individuals should consider more frequent dermatologist check-ups:

UV Exposure

• History of sunburns, especially blistering sunburns during childhood
• Prolonged or occupational outdoor sun exposure
• History of indoor tanning bed use (tanning beds increase melanoma risk significantly)
• Living at higher altitude or latitudes with intense UV radiation

Personal and Family History

• Previous skin cancer (any type) — significantly increases risk of a subsequent skin cancer
• Family history of melanoma — approximately 10% of melanoma cases occur in people with a family history
• Large numbers of moles (>50) — increases melanoma risk
• Presence of atypical (dysplastic) nevi — moles with irregular features that are not yet cancerous but may be precursors

Skin and Biological Factors

• Fair skin, light hair, and light eyes (Fitzpatrick skin types I and II) — have less melanin to shield UV damage
• A history of easy sunburning rather than tanning
• Age over 50 — particularly for men; melanoma rates in men over 50 increase substantially compared to younger adults
• Immune suppression — organ transplant recipients or people taking immunosuppressive medications are at significantly higher risk

Genetic Conditions

• Gorlin syndrome (basal cell naevus syndrome) — a hereditary condition causing multiple BCCs
• Xeroderma pigmentosum — impaired DNA repair greatly amplifies UV damage

Sun Protection: The Primary Prevention Strategy

UV radiation — from both sun exposure and artificial tanning devices — is the primary modifiable risk factor for all three major skin cancer types. The AAD's prevention strategy:

• Broad-spectrum sunscreen SPF 30+, applied to all exposed skin 15–30 minutes before outdoor exposure, reapplied every 2 hours and after swimming or sweating
• Protective clothing — UPF-rated shirts, wide-brimmed hats, UV-blocking sunglasses
• Shade-seeking during peak UV hours (10am–4pm)
• Avoiding tanning beds entirely — the World Health Organization classifies tanning devices as a Group 1 carcinogen
• Reapplication discipline — sunscreen degrades with UV exposure and sweating; reapplication is not optional

When to See a Dermatologist

The AAD's guidance is unambiguous: see a board-certified dermatologist immediately if you notice anything on your skin that is changing, itching, or bleeding. More specifically, seek evaluation for:

• Any mole or spot that displays one or more ABCDE features
• The ugly duckling — a lesion that looks distinctly different from your other moles
• A raised, firm, fast-growing nodule (EFG criteria for nodular melanoma)
• A sore that bleeds spontaneously or fails to heal within 3–4 weeks
• A dark stripe or band under a fingernail or toenail, particularly with associated skin darkening around the nail base
• A new lesion in a sun-protected area, in someone with darker skin, or in a child
• Any change in a pre-existing mole, even subtle

Annual professional skin exams — during which a dermatologist systematically examines every inch of skin — are recommended for anyone with elevated risk factors. Early detection remains the single most powerful tool for improving skin cancer outcomes: early-stage melanoma is highly curable, while metastatic melanoma remains difficult to treat despite advances in immunotherapy and targeted therapy.